Quantcast

Latest radiation treatments Stories

2010-11-04 08:00:00

THE WOODLANDS, Texas, Nov. 4, 2010 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), reported revenue growth in the third quarter of 2010 of 4.3 percent to $940.7 million from $901.5 million in the same period in 2009. Adjusted EBITDA of $55.7 million in the third quarter of 2010 decreased from $62.1 million in the same period in 2009 (see definition of Adjusted EBITDA in "Discussion of Non-GAAP Information" in this release). (Logo:...

2010-08-05 08:39:00

THE WOODLANDS, Texas, Aug. 5 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), reported revenue growth in the second quarter of 2010 of 4.2 percent to $918.4 million from $881.6 million in the same period in 2009. Adjusted EBITDA of $56.6 million in the second quarter of 2010 decreased from $62.7 million in the same period in 2009 (see definition of Adjusted EBITDA in "Discussion of Non-GAAP Information" in this release). (Logo:...

2010-05-06 08:15:00

THE WOODLANDS, Texas, May 6 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), reported revenue growth in the first quarter of 2010 of 4.5 percent to $880.5 million from $842.6 million in the same period in 2009. Adjusted EBITDA of $55.2 million in the first quarter of 2010 increased slightly from $55.1 million in the same period in 2009 (see definition of Adjusted EBITDA in "Discussion of Non-GAAP Information" in this release). Additional highlights for the first...

2010-02-25 08:00:00

THE WOODLANDS, Texas, Feb. 25 /PRNewswire/ -- US Oncology, Inc. ("US Oncology" or "the Company"), reported revenue growth in the fourth quarter of 2009 of 5.1 percent to $886.0 million from $842.7 million in the same period in 2008. Adjusted EBITDA increased by 10.7 percent in the fourth quarter of 2009 to $61.1 million from $55.2 million in the same period in 2008 (see definition of Adjusted EBITDA in "Discussion of Non-GAAP Information" in this release). For the 2009 fiscal year, the...

2008-08-07 18:01:53

TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it will introduce the TomoDirect(TM) discrete-angle delivery mode(1) for the TomoTherapy(R) Hi-Art(R) treatment system at two upcoming radiation oncology conferences. This innovative new technology allows Hi-Art system users to quickly plan and deliver advanced TomoTherapy(SM) radiation treatments with a series of linear beam paths, rather than the existing helical path. With TomoDirect, clinicians can choose several discrete angles...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related